New England Research & Management’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-13,045
| Closed | -$1.21M | – | 166 |
|
|
2022
Q2 | $1.21M | Buy |
13,045
+7,850
| +151% | +$728K | 0.7% | 46 |
|
|
2022
Q1 | $526K | Buy |
5,195
+50
| +1% | +$5.06K | 0.27% | 104 |
|
|
2021
Q4 | $531K | Hold |
5,145
| – | – | 0.26% | 107 |
|
|
2021
Q3 | $437K | Sell |
5,145
-12,965
| -72% | -$1.1M | 0.23% | 115 |
|
|
2021
Q2 | $1.51M | Sell |
18,110
-6,487
| -26% | -$541K | 0.78% | 47 |
|
|
2021
Q1 | $1.85M | Buy |
24,597
+19,162
| +353% | +$1.44M | 1.01% | 28 |
|
|
2020
Q4 | $371K | Sell |
5,435
-3,800
| -41% | -$259K | 0.23% | 114 |
|
|
2020
Q3 | $539K | Sell |
9,235
-16,265
| -64% | -$949K | 0.39% | 87 |
|
|
2020
Q2 | $1.66M | Sell |
25,500
-700
| -3% | -$45.5K | 1.19% | 19 |
|
|
2020
Q1 | $1.55M | Buy |
26,200
+2,316
| +10% | +$137K | 1.33% | 18 |
|
|
2019
Q4 | $1.77M | Sell |
23,884
-4,116
| -15% | -$306K | 1.19% | 19 |
|
|
2019
Q3 | $1.77M | Sell |
28,000
-6,950
| -20% | -$438K | 1.28% | 16 |
|
|
2019
Q2 | $1.9M | Buy |
34,950
+1,300
| +4% | +$70.8K | 1.29% | 17 |
|
|
2019
Q1 | $1.82M | Buy |
33,650
+12,650
| +60% | +$682K | 1.23% | 20 |
|
|
2018
Q4 | $1.38M | Buy |
+21,000
| New | +$1.38M | 1.08% | 25 |
|
|
2017
Q3 | – | Sell |
-2,705
| Closed | -$218K | – | 163 |
|
|
2017
Q2 | $218K | Sell |
2,705
-11,525
| -81% | -$929K | 0.16% | 148 |
|
|
2017
Q1 | $1.12M | Buy |
14,230
+150
| +1% | +$11.8K | 0.86% | 36 |
|
|
2016
Q4 | $1.11M | Sell |
14,080
-805
| -5% | -$63.5K | 0.87% | 31 |
|
|
2016
Q3 | $1.33M | Buy |
14,885
+4,200
| +39% | +$374K | 1.11% | 20 |
|
|
2016
Q2 | $1.02M | Buy |
10,685
+1,300
| +14% | +$124K | 0.88% | 37 |
|
|
2016
Q1 | $974K | Sell |
9,385
-625
| -6% | -$64.9K | 0.83% | 38 |
|
|
2015
Q4 | $979K | Buy |
10,010
+4,400
| +78% | +$430K | 0.85% | 33 |
|
|
2015
Q3 | $541K | Buy |
+5,610
| New | +$541K | 0.51% | 70 |
|